COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 165 filers reported holding COHERUS BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,033,078 | +45.6% | 276,224 | +66.2% | 0.52% | +55.4% |
| Q2 2023 | $709,572 | -37.5% | 166,176 | +0.1% | 0.34% | -41.1% |
| Q1 2023 | $1,136,028 | +85962.7% | 166,086 | -0.4% | 0.57% | -15.8% |
| Q4 2022 | $1,320 | -99.9% | 166,722 | -0.7% | 0.68% | -23.5% |
| Q3 2022 | $1,613,000 | +37.4% | 167,867 | +3.5% | 0.88% | +42.5% |
| Q2 2022 | $1,174,000 | -44.0% | 162,146 | -0.2% | 0.62% | -36.6% |
| Q1 2022 | $2,097,000 | -19.5% | 162,432 | -0.5% | 0.98% | -8.8% |
| Q4 2021 | $2,605,000 | -0.7% | 163,198 | -0.0% | 1.07% | -9.7% |
| Q3 2021 | $2,623,000 | +19.7% | 163,210 | +3.0% | 1.19% | +59.3% |
| Q2 2021 | $2,191,000 | -8.6% | 158,427 | -3.4% | 0.75% | -5.9% |
| Q1 2021 | $2,396,000 | +17.1% | 164,029 | +39.3% | 0.79% | +2.3% |
| Q4 2020 | $2,046,000 | -6.2% | 117,731 | -1.0% | 0.78% | -25.5% |
| Q3 2020 | $2,182,000 | – | 118,955 | – | 1.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |